Duocarmazine is an investigational antibody-drug conjugate designed to target HER2-positive cancers. This therapeutic agent functions by delivering a potent cytotoxic DNA-alkylating payload directly to… Read more
Duocarmazine is an investigational antibody-drug conjugate designed to target HER2-positive cancers. This therapeutic agent functions by delivering a potent cytotoxic DNA-alkylating payload directly to tumor cells; once the antibody binds to its target and is internalized, a cleavable linker releases the active drug, which subsequently binds to the DNA minor groove to induce irreparable damage and cell death. The comprehensive range of related compounds, including impurities, metabolites, and stable isotope labelled standards, is essential for pharmaceutical laboratories performing rigorous analytical testing and quality control. By providing the high-quality materials necessary for accurate impurity profiling and precise method validation, these reference standards ensure consistency throughout the development and clinical evaluation of this complex oncology product. Laboratories rely on these high-purity compounds to characterize the pharmacological profile and structural integrity of the conjugate throughout its lifecycle.